Page last updated: 2024-12-08
enkephalin-met, lys(6)-
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
enkephalin-Met, Lys(6)-: opioid hexapeptide found in adrenal medulla & brain [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 189848 |
MeSH ID | M0092155 |
Synonyms (16)
Synonym |
---|
enkephalin-met, lys(6)- |
75909-25-0 |
(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]hexanoic acid |
6-lysine-5-methionine-enkephalin |
l-lysine, n2-(n-(n-(n-(n-l-tyrosylglycyl)glycyl)-l-phenylalanyl)-l-methionyl)- |
enkephalin-met, lysine(6)- |
met-enk-l |
methionine-enkephalin, lys(6)- |
6-lys-met-enkephalin |
met-enkephalin, lys(6)- |
h-tyr-gly-gly-phe-met-lys-oh acetate salt |
AKOS030525638 |
h-tyr-gly-gly-phe-met-lys-oh |
n~2~-{14-amino-5-benzyl-1,4,7,10,13-pentahydroxy-15-(4-hydroxyphenyl)-2-[2-(methylsulfanyl)ethyl]-3,6,9,12-tetraazapentadeca-3,6,9,12-tetraen-1-ylidene}lysine |
DTXSID80997287 |
l-tyrosylglycylglycyl-l-phenylalanyl-l-methionyl-l-lysine |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.51
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |